STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Clinical trials for STAGE III HEPATOCELLULAR CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III HEPATOCELLULAR CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III HEPATOCELLULAR CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo enters early trial for Tough-to-Treat digestive cancers
Disease control OngoingThis early-stage study is testing a combination of two drugs, guadecitabine and durvalumab, in people with advanced cancers of the liver, pancreas, bile duct, or gallbladder that have spread. The main goals are to find the safest dose and see what side effects occur. Researchers …
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Precision proton beams battle standard radiation in liver cancer showdown
Disease control OngoingThis study compares two types of radiation therapy for patients with liver cancer that cannot be removed by surgery. Researchers want to see if proton therapy, which can target tumors more precisely, helps patients live longer with fewer side effects than standard photon radiatio…
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC